WO2022100195A1 - Procédé de préparation de chlorure de 2-fluoro-5-méthoxybenzènesulfonyle - Google Patents
Procédé de préparation de chlorure de 2-fluoro-5-méthoxybenzènesulfonyle Download PDFInfo
- Publication number
- WO2022100195A1 WO2022100195A1 PCT/CN2021/114067 CN2021114067W WO2022100195A1 WO 2022100195 A1 WO2022100195 A1 WO 2022100195A1 CN 2021114067 W CN2021114067 W CN 2021114067W WO 2022100195 A1 WO2022100195 A1 WO 2022100195A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluoro
- metal
- chloride
- methoxybenzenesulfonyl chloride
- lithium
- Prior art date
Links
- MEOZOFVLIUUROW-UHFFFAOYSA-N 2-fluoro-5-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(F)C(S(Cl)(=O)=O)=C1 MEOZOFVLIUUROW-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 8
- 229910052751 metal Inorganic materials 0.000 claims abstract description 22
- 239000002184 metal Substances 0.000 claims abstract description 22
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 10
- LYIGJBQYDRJPIR-UHFFFAOYSA-N 2-bromo-1-fluoro-4-methoxybenzene Chemical compound COC1=CC=C(F)C(Br)=C1 LYIGJBQYDRJPIR-UHFFFAOYSA-N 0.000 claims abstract description 8
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 125000003118 aryl group Chemical group 0.000 claims abstract description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 10
- -1 alkyl magnesium Chemical compound 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 20
- 238000009776 industrial production Methods 0.000 abstract description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000007788 liquid Substances 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000002390 rotary evaporation Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 108010022404 serum-glucocorticoid regulated kinase Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- DBTNVRCCIDISMV-UHFFFAOYSA-L lithium;magnesium;propane;dichloride Chemical compound [Li+].[Mg+2].[Cl-].[Cl-].C[CH-]C DBTNVRCCIDISMV-UHFFFAOYSA-L 0.000 description 2
- LVKCSZQWLOVUGB-UHFFFAOYSA-M magnesium;propane;bromide Chemical compound [Mg+2].[Br-].C[CH-]C LVKCSZQWLOVUGB-UHFFFAOYSA-M 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 description 1
- 101000890668 Homo sapiens Free fatty acid receptor 2 Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- BBPAICDPWINHGF-UHFFFAOYSA-N O=S(NC(C=C1)=CC=C1C1=CC=C(C=NN2)C2=C1)=O Chemical compound O=S(NC(C=C1)=CC=C1C1=CC=C(C=NN2)C2=C1)=O BBPAICDPWINHGF-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- WXJBZPDYIKQTBZ-UHFFFAOYSA-L [Li+].[Cl-].[Br-].CC(C)[Mg+] Chemical compound [Li+].[Cl-].[Br-].CC(C)[Mg+] WXJBZPDYIKQTBZ-UHFFFAOYSA-L 0.000 description 1
- 150000004791 alkyl magnesium halides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- FQYGKMVSWVJCJG-UHFFFAOYSA-N n-[4-(3-amino-2h-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]-2-fluoro-5-methoxybenzenesulfonamide Chemical compound COC1=CC=C(F)C(S(=O)(=O)NC=2C=CC(=CC=2)C2=NC3=NNC(N)=C3C=N2)=C1 FQYGKMVSWVJCJG-UHFFFAOYSA-N 0.000 description 1
- KYUKUHICYOEKSV-UHFFFAOYSA-N n-[4-[4-(1-acetylpiperidin-4-yl)oxy-3-methyl-2h-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-2-fluoro-5-methoxybenzenesulfonamide Chemical compound COC1=CC=C(F)C(S(=O)(=O)NC=2C=CC(=CC=2)C2=NC3=NNC(C)=C3C(OC3CCN(CC3)C(C)=O)=N2)=C1 KYUKUHICYOEKSV-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/78—Halides of sulfonic acids
- C07C309/86—Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/87—Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
Definitions
- the present disclosure belongs to the field of medicinal chemistry, and in particular relates to a method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride.
- 2-Fluoro-5-methoxybenzenesulfonyl chloride (CAS number: 1214334-01-6), whose structure is shown in formula I, is an important intermediate for the synthesis of various new drugs.
- Patent WO2014140065 discloses a new compound, N-(4-(azaindol-6-yl)-phenyl)-sulfonamide, which is a valuable pharmacologically active compound that modulates protein kinase activity, especially Serum and glucocorticoid-regulated kinase (SGK) activity is a potential drug for the treatment of diseases with inappropriate SGK activity, such as degenerative joint diseases or inflammatory processes such as osteoarthritis or rheumatism.
- SGK Serum and glucocorticoid-regulated kinase
- Patent WO2015198045 discloses new compounds, 3-substituted 2-aminoindole derivatives and analogs, which are potential drugs for the treatment or prevention of GPR43 receptor-related disorders, such as diabetes, obesity and inflammatory bowel disease.
- 2-fluoro-5-methoxybenzenesulfonyl chloride is an important raw material for the synthesis of related compounds, and the synthetic route is shown in Scheme 1.
- the purpose of the present disclosure is to provide a preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride which is easy to operate and easy to industrialize in view of the deficiencies of the prior art.
- X is selected from F, Cl, Br and I; M is selected from Mg, Zn, Li and combinations thereof.
- the operation steps are: using 3-bromo-4-fluoroanisole as raw material, reacting with metal or metal reagent to obtain aryl metal reagent III, and then reacting with sulfonyl chloride to obtain 2-fluoro-5-methoxyl group Benzenesulfonyl chloride.
- the metal or metal reagent is selected from the group consisting of C 1 -C 6 straight or branched alkyl magnesium, C 1 -C 6 straight or branched alkyl magnesium halide, lithium halide, C 1 -C 6 One or a mixture of linear or branched alkyl lithium, metal magnesium, metal zinc, and metal lithium.
- the metal or metal reagent is selected from magnesium metal, C1 - C6 straight or branched alkyl magnesium, C1 - C6 straight or branched alkyl magnesium halide lithium halide.
- the metal reagent is selected from the group consisting of isopropylmagnesium chloride lithium chloride, isopropylmagnesium bromide lithium chloride, isopropylmagnesium chloride, isopropylmagnesium bromide, preferably isopropylmagnesium chloride lithium chloride .
- the beneficial effect of the present disclosure is that the present disclosure provides a new and unreported preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride, using 3-bromo-4-fluoroanisole as a raw material,
- the reaction steps are short, the operation is simple, the reaction conditions are mild, and the method is suitable for industrial production.
- the tetrahydrofuran was removed by rotary evaporation, extracted with dichloromethane, washed with water, and rotary evaporation was performed to obtain a brown liquid, and oil pump distillation was used to obtain 4.2 g of a colorless liquid.
- the 1 H NMR chart is shown in FIG. 1 .
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La présente invention concerne un procédé de préparation de chlorure de 2-fluoro-5-méthoxybenzènesulfonyle. Le 3-bromo-4-fluoroanisole est utilisé en tant que matière première et réagit avec un métal ou un réactif métallique pour obtenir un réactif métallique aryle, qui réagit ensuite avec du chlorure de sulfonyle pour obtenir du chlorure de 2-fluoro-5-méthoxybenzènesulfonyle. Le procédé selon la présente invention présente des étapes de réaction courtes, un fonctionnement simple et des conditions de réaction modérées, et est approprié pour une production industrielle.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011278152.XA CN114507163A (zh) | 2020-11-16 | 2020-11-16 | 一种制备2-氟-5-甲氧基苯磺酰氯的方法 |
CN202011278152.X | 2020-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022100195A1 true WO2022100195A1 (fr) | 2022-05-19 |
Family
ID=81546439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/114067 WO2022100195A1 (fr) | 2020-11-16 | 2021-08-23 | Procédé de préparation de chlorure de 2-fluoro-5-méthoxybenzènesulfonyle |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114507163A (fr) |
WO (1) | WO2022100195A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012407A (zh) * | 2011-09-27 | 2013-04-03 | 赛诺菲 | N-[4-(1H-吡唑并[3,4-b]吡嗪-6-基)-苯基]-磺酰胺类及其作为药物的用途 |
CN108003161A (zh) * | 2016-10-28 | 2018-05-08 | 正大天晴药业集团股份有限公司 | 神经营养因子酪氨酸激酶受体抑制剂 |
CN109593803A (zh) * | 2018-12-24 | 2019-04-09 | 上海健康医学院 | (r)-2-(2,5-二氟苯基)吡咯烷或其盐的制备方法 |
CN109593802A (zh) * | 2018-12-24 | 2019-04-09 | 上海健康医学院 | 一种(r)-2-(2,5-二氟苯基)吡咯烷或其盐的制备方法 |
WO2020079205A1 (fr) * | 2018-10-19 | 2020-04-23 | Les Laboratoires Servier | Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant |
CN111647011A (zh) * | 2020-07-16 | 2020-09-11 | 宁夏中星显示材料有限公司 | 一种单卤代苯硼酸的制备方法 |
-
2020
- 2020-11-16 CN CN202011278152.XA patent/CN114507163A/zh active Pending
-
2021
- 2021-08-23 WO PCT/CN2021/114067 patent/WO2022100195A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012407A (zh) * | 2011-09-27 | 2013-04-03 | 赛诺菲 | N-[4-(1H-吡唑并[3,4-b]吡嗪-6-基)-苯基]-磺酰胺类及其作为药物的用途 |
CN108003161A (zh) * | 2016-10-28 | 2018-05-08 | 正大天晴药业集团股份有限公司 | 神经营养因子酪氨酸激酶受体抑制剂 |
WO2020079205A1 (fr) * | 2018-10-19 | 2020-04-23 | Les Laboratoires Servier | Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant |
CN109593803A (zh) * | 2018-12-24 | 2019-04-09 | 上海健康医学院 | (r)-2-(2,5-二氟苯基)吡咯烷或其盐的制备方法 |
CN109593802A (zh) * | 2018-12-24 | 2019-04-09 | 上海健康医学院 | 一种(r)-2-(2,5-二氟苯基)吡咯烷或其盐的制备方法 |
CN111647011A (zh) * | 2020-07-16 | 2020-09-11 | 宁夏中星显示材料有限公司 | 一种单卤代苯硼酸的制备方法 |
Non-Patent Citations (6)
Title |
---|
BHATTACHARYA S. N., EABORN C., WALTON D. R. M.: "Preparation of arenesulphonyl chlorides from Grignard reagents", JOURNAL OF THE CHEMICAL SOCIETY, SECTION C: ORGANIC CHEMISTRY.>6015C, CHEMICAL SOCIETY. LETCHWORTH., GB, 1 January 1968 (1968-01-01), GB , pages 1265, XP055930352, ISSN: 0022-4952, DOI: 10.1039/j39680001265 * |
DAVIES ALYN T., CURTO JOHN M., BAGLEY SCOTT W., WILLIS MICHAEL C.: "One-pot palladium-catalyzed synthesis of sulfonyl fluorides from aryl bromides", CHEMICAL SCIENCE, ROYAL SOCIETY OF CHEMISTRY, UNITED KINGDOM, vol. 8, no. 2, 1 January 2017 (2017-01-01), United Kingdom , pages 1233 - 1237, XP055930360, ISSN: 2041-6520, DOI: 10.1039/C6SC03924C * |
HAY J. V.: "CHEMISTRY OF SULFONYLUREA HERBICIDES.", PESTICIDE SCIENCE., ELSEVIER APPLIED SCIENCE PUBLISHER. BARKING., GB, vol. 29., no. 03., 1 January 1990 (1990-01-01), GB , pages 247 - 261., XP000202810, ISSN: 0031-613X * |
LEO A. PAQUETTE: "Encyclopedia of reagents for organic synthesis; Vol. 7 : Sod - Trim", WILEY , Chichester , ISBN: 978-0-470-84289-8, article ANILKUMAR R., BURTON DONALD J.: "Chloropentafluorobenzene", XP055930355, DOI: 10.1002/047084289X.rn00539 * |
MICHAEL A. WALLACE, CONRAD E. RAAB, DENNIS C. DEAN, DAVID G. MELILLO: "Synthesis of [35S]aryl sulfonyl chlorides from [35S]elemental sulfur", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, JOHN WILEY & SONS LTD., GB, vol. 48, no. 4, 30 March 2005 (2005-03-30), GB , pages 275 - 283, XP055661462, ISSN: 0362-4803, DOI: 10.1002/jlcr.920 * |
ZEKRI NEGAR; FAREGHI-ALAMDARI REZA; MOMENI-FARD BEHNAZ: "Synthesis of ketamine from a nontoxic procedure: a new and efficient route", JOURNAL OF CHEMICAL SCIENCES, SPRINGER INDIA, NEW DELHI, vol. 132, no. 1, 25 September 2020 (2020-09-25), New Delhi, XP037255628, ISSN: 0974-3626, DOI: 10.1007/s12039-020-01827-9 * |
Also Published As
Publication number | Publication date |
---|---|
CN114507163A (zh) | 2022-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0570594B1 (fr) | Derive d'acide hydroxamique a base de sulfonamide aromatique | |
SU873875A3 (ru) | Способ получени производных о-метилбензанилида | |
CA3082115A1 (fr) | Processus pour la preparation de tapinarof | |
JPH03128343A (ja) | 改良治療特性を有する抗炎症薬の新規亜鉛誘導体 | |
US3987091A (en) | 11,12-secoprostaglandins | |
US3120551A (en) | 5-(4-biphenylyl)-3-methylvaleric acid and functional derivatives thereof | |
US4159279A (en) | Nuclear substituted 2-hydroxyphenylmethanesulfamic acids | |
WO2022100195A1 (fr) | Procédé de préparation de chlorure de 2-fluoro-5-méthoxybenzènesulfonyle | |
Fieser et al. | The Addition of Dichlorocarbene to cis, cis-1, 5-Cyclooctadiene | |
US4091107A (en) | 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins | |
US3096372A (en) | Novel nu-(substituted)-phenylsulfonyl-n'-1-adamantylureas | |
US3873539A (en) | Substituted-4-aminoacetyl alkanoylphenones | |
Henry | The Reaction of Amines with N-Methyl-N-nitroso-N'-nitroguanidine | |
JPH0567142B2 (fr) | ||
Haynes | The Synthesis of 1, 2, 3, Triphenylpropane | |
FI70711C (fi) | Foerfarande foer framstaellning av en farmakologiskt aktiv hoegervridande isomer av (+)-ozolinon-ester | |
US4273787A (en) | 1-Alkyl,1-phenyl-butenes | |
US3598861A (en) | 2-(5'-phenyl-m-terphenyl - 4 - yloxy) lower aliphatic monocarbocyclic acids and esters thereof | |
EP0013726B1 (fr) | Dérivés d'acide indanyloxamique, leur préparation et préparations pharmaceutiques les contenant | |
JPS5857419B2 (ja) | 1−シクロプロピル−1−フエニル−ω−アミノ−1−低級アルカノイルオキシアルカン類の製造方法 | |
Hammond et al. | New synthesis of 1-azabicyclo [5.3. 0] decane | |
US4049825A (en) | Aminoalkylethers; composition and method of use | |
JPS5919537B2 (ja) | オキシインド−ル誘導体 | |
US2293877A (en) | Amino compound | |
KR860000263B1 (ko) | 아세토니트릴로부터 디-치환된 니트릴 유도체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21890724 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21890724 Country of ref document: EP Kind code of ref document: A1 |